Based on these ROC curves, LASPGFPGEYANDQERR3 (=MASP2), TFISPIK2 (=C3), VTAAPQSVCALR2 (=A2M), KTPEELLR2 (=CHMP2A) and SVDPDSPAEASGLR2 (=NHE-RF1) have a high discriminating power between the bladder cancer patients and the healthy control group and might be good biomarker candidates. This evidence concerns the gene MASP2 and urinary bladder cancer.